Fatty Liver Disease: The 2 Billion Person Epidemic No One Is Talking About

About this episode

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD), affects up to 38% of the global adult population—making it one of the most prevalent chronic diseases worldwide. Yet most people have never heard of it.

In this episode, we dive deep into the science behind fatty liver disease, exploring how our modern lifestyle has created a perfect storm for liver dysfunction. From insulin resistance to dietary triggers, we examine the mechanisms driving this epidemic and, more importantly, what you can do about it.

Dr. Kash Gupta breaks down the latest research on lifestyle interventions, including evidence-based nutrition strategies, exercise protocols, and emerging treatments that show real promise in reversing liver fat accumulation.

Key takeaways

• MASLD affects nearly 2 billion people globally and is closely linked to metabolic syndrome
• You don't need to be overweight to develop fatty liver disease—it can affect lean individuals too
• Just 5-10% weight loss can significantly reduce liver fat and inflammation
• Resistance training combined with aerobic exercise shows superior results for liver health
• Certain dietary patterns (Mediterranean, low-carb) have strong evidence for reversing MASLD
• Regular monitoring is crucial—many people are asymptomatic until advanced stages

Episode timeline

1. 00:00Introduction to fatty liver disease and why it matters
2. 05:30The difference between MASLD and NAFLD: new terminology explained
3. 12:15Risk factors and who is most susceptible
4. 18:45The gut-liver axis and its role in disease progression
5. 26:00Dietary interventions that actually work
6. 35:20Exercise protocols for liver health optimization
7. 42:10Supplements and medications: what the evidence shows
8. 48:30Action steps and key recommendations